Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A injection plus splinting for base-of-thumb osteoarthritis
2016-003939-38Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Rhizarthrosis comparing BOTOX plus splinting with Saline placebo plus splinting (2 arms). Primary endpoint: Pain at 3 months. Started Jun 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2016-003939-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003939-38.